For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict ...
The Biden-Harris administration proposed a new rule on Tuesday that would expand coverage of the anti-obesity medications ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
1h
If you’re taking a GLP-1 medication, some foods should be avoided — including a traditional favorite Getty There are a few ...
Amgen's (AMGN) once-monthly GLP-1, which experts expect to be a game changer in the weight-loss space, is showing continued ...
MariTide, which like Eli Lilly’s Zepound is a dual agonist of the GLP-1 and GIP receptors, demonstrated an average weight ...
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were mostly higher early Tuesday after the Biden administration proposed a rule that would allow Medicare ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
The Biden administration is set to propose legislation allowing Medicare and Medicaid to cover the cost of GLP-1 obesity meds ...
The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...
The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback